Table 3.
ARV | Potential interaction with substances of abuse |
---|---|
Efavirenz | Enhanced cannabis effect by CYP3A4 inhibition |
Precipitated methadone withdrawal by CYP3A4 induction | |
Ritonavir | Enhanced oxycodone effect by CYP2D6 inhibition |
Enhanced MDMA effect by CYP2D6 inhibition | |
Enhanced GHB effect by CYP450 inhibition | |
Nevirapine | Precipitated methadone withdrawal by CYP3A4 induction |